Isopropylethylamine → (RS)-4-chloro-N-ethyl-N-isopropyl-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxamide

HRID 930981Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 930981
[Cl:1][C:2]1[C:3]2[C:10]3[CH2:11][CH2:12][CH:13]([C:15]([OH:17])=O)[CH2:14][C:9]=3[S:8][C:4]=2[N:5]=[CH:6][N:7]=1.[CH2:18]([NH:20][CH:21]([CH3:23])[CH3:22])[CH3:19]>>[Cl:1][C:2]1[C:3]2[C:10]3[CH2:11][CH2:12][CH:13]([C:15]([N:20]([CH2:18][CH3:19])[CH:21]([CH3:23])[CH3:22])=[O:17])[CH2:14][C:9]=3[S:8][C:4]=2[N:5]=[CH:6][N:7]=1

Komponenten

3

Versuchsvorschrift

500 mg (1.86 mmol) (RS)-4-chloro-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidine-7-carboxylic acid (prepared according to intermediate example 31b) were transformed in analogy to example 3 using N-ethylpropan-2-amine to give after working up and purification 513 mg (82%) of the title compound.

Aufarbeitung

  1. customto give
  2. custompurification 513 mg (82%) of the title compound

Quellen und Nachweise

ORD-Eintrag
ord-130f393008d946e399568a6220379ad2
Quelldatensatz
uspto-grants-2016_03
Patentnummer
US09296757B2

Notizen zur Reaktion

Wird geladen…